阳光诺和(688621)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688621 阳光诺和

已收盘 04-30 15:00:00

{"stockData":{"symbol":"688621","market":"SH","secType":"STK","nameCN":"阳光诺和","latestPrice":56.35,"timestamp":1714460400000,"preClose":57.69,"halted":0,"volume":1392605,"delay":0,"floatShares":81102700,"shares":112000000,"eps":1.8712,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.34,"latestTime":"04-30 15:00:00","open":57.3,"high":58.5,"low":56.31,"amount":79766600,"amplitude":0.038,"askPrice":56.36,"askSize":13,"bidPrice":56.35,"bidSize":22,"shortable":0,"etf":0,"ttmEps":1.8712,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":57.69,"symbolType":"stock_kcb","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":63.46,"lowLimit":51.92,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":112000000,"pbRate":6.22,"roa":"--","roe":"7.44%","epsLYR":1.65,"committee":0.142857,"marketValue":6311000000,"floatMarketCap":4570000000,"peRate":30.114366,"changeRate":-0.0232,"turnoverRate":0.0172,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-06。","afterMarket":{"amount":0,"volume":0,"close":56.35,"buyVolume":0,"sellVolume":0,"time":1714462439505,"indexStatus":"已收盘 04-30 15:30:00","preClose":57.69}},"requestUrl":"/m/hq/s/688621/wiki","defaultTab":"wiki","newsList":[{"id":"2431863560","title":"阳光诺和获华安证券买入评级，一季度利润端超预期，新签订单持续高增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2431863560","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431863560?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:24","pubTimestamp":1714397075,"startTime":"0","endTime":"0","summary":"4月29日，阳光诺和获华安证券买入评级，近一个月阳光诺和获得3份研报关注。研报认为，阳光诺和2023年实现营业收入9.32亿元，同比增长37.76%；实现归母净利润1.85亿元，同比增长18.08%。1Q24实现营业收入2.52亿元，同比增长8.53%；实现归母净利润0.73亿元，同比增长51.77%。2023年新签订单15.04亿元，同比增长36.50%；累计存量订单25.66亿，同比增长28.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921243987bf949f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921243987bf949f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431505638","title":"华安证券：给予阳光诺和买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431505638","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431505638?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:02","pubTimestamp":1714395727,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超近期对阳光诺和进行研究并发布了研究报告《一季度利润端超预期，新签订单持续高增长》，本报告对阳光诺和给出买入评级，当前股价为57.69元。我们维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级7家，增持评级1家；过去90天内机构目标均价为74.06。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900030950.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431070283","title":"阳光诺和(688621)23年报&24年一季报点评：业绩稳定增长，自研成果积极兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2431070283","media":"东方证券","top":-1,"share":"https://www.laohu8.com/m/news/2431070283?lang=zh_cn&edition=full","pubTime":"2024-04-29 14:17","pubTimestamp":1714371450,"startTime":"0","endTime":"0","summary":"24年一季度实现：营业收入2.52亿元，同比增长8.5%；归母净利润0.73亿元，同比增长51.8%。公司业绩的稳定增长主要来自于公司突出的研发能力，并不断加强一体化的能力建设，打造国内一流的一站式药物研发服务平台。2023年公司新签订单15.04亿元，同比增长36.50%；累计存量订单25.66亿元，同比增长28.69%，充足的在手订单为公司未来的发展奠定良好基础。2)临床试验及生物分析业务实现收入3.6亿元，同比快速增长54.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291430348b609583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291430348b609583&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430377299","title":"阳光诺和获民生证券买入评级，Q1利润端增长大超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430377299","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430377299?lang=zh_cn&edition=full","pubTime":"2024-04-28 08:33","pubTimestamp":1714264396,"startTime":"0","endTime":"0","summary":"2024年4月28日，阳光诺和获民生证券买入评级，近一个月阳光诺和获得2份研报关注。研报预计2024-2026年公司收入为12.44/16.46/21.61亿元，同比增长33.4%/32.4%/31.2%，归母净利润分别为2.50/3.33/4.40亿元。研报认为，阳光诺和是特色的仿创结合药物研发服务公司，预期24年Q2起收入端将高速增长。一季度临床订单交付存在季节性波动，但是在23Q1高基数的基础上收入端仍稳健增长，利润端大幅提升，预期未来几个季度公司收入和利润端将持续高增长趋势。风险提示：研发失败风险、开发周期较长的风险、管理风险、行业监管政策风险、安全生产风险等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042808352887b8d487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042808352887b8d487&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430464774","title":"民生证券给予阳光诺和推荐评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430464774","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430464774?lang=zh_cn&edition=full","pubTime":"2024-04-28 08:19","pubTimestamp":1714263540,"startTime":"0","endTime":"0","summary":"民生证券04月27日发布研报称，给予阳光诺和（688621.SH，最新价：56.83元）推荐评级。评级理由主要包括：1）药学研究和临床服务双轮驱动，持续扩展多元化业务领域；2）自主研发管线快速扩张，下游客户研发需求保持旺盛。风险提示：研发失败风险、开发周期较长的风险、管理风险、行业监管政策风险、安全生产风险等。AI点评：阳光诺和近一个月获得1份券商研报关注，买入1家，平均目标价为85元，与最新价56.83元相比，高28.17元，目标均价涨幅49.57%。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404280821598b5c07ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404280821598b5c07ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430890798","title":"阳光诺和(688621)：Q1利润端增长大超预期 一站式CRO业务需求旺盛","url":"https://stock-news.laohu8.com/highlight/detail?id=2430890798","media":"民生证券股份有...","top":-1,"share":"https://www.laohu8.com/m/news/2430890798?lang=zh_cn&edition=full","pubTime":"2024-04-27 13:52","pubTimestamp":1714197164,"startTime":"0","endTime":"0","summary":"事件：2024 年4 月25 日，阳光诺和发布2023 年年报。2024 年Q1 公司实现收入2.52 亿元，同比增长8.53%；归母净利润0.73 亿元，同比上升51.77%；扣非归母净利润0.67 亿元，同比增长41.68%，利润端增长大超预期。药学研究板块2023 年营收5.69 亿元，同比上升28.67%，毛利率为67.41%；截至2023年末药学研究人员达到1002 人，同比增长20.00%。投资建议：阳光诺和是特色的仿创结合药物研发服务公司，预期24 年Q2起收入端将高速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404271352498b59ac21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404271352498b59ac21&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430575650","title":"阳光诺和（688621）4月26日主力资金净卖出302.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430575650","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430575650?lang=zh_cn&edition=full","pubTime":"2024-04-27 07:57","pubTimestamp":1714175878,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月26日收盘，阳光诺和报收于56.83元，下跌1.81%，换手率3.81%，成交量3.09万手，成交额1.71亿元。近5日资金流向一览见下表：阳光诺和融资融券信息显示，融资方面，当日融资买入1768.4万元，融资偿还707.29万元，融资净买入1061.11万元。阳光诺和主营业务：创新药开发,仿制药开发及一致性评价等方面的综合研发服务,服务内容主要包括药物发现,药学研究,临床试验和生物分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700018741.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430302228","title":"阳光诺和(688621)3月31日股东户数0.38万户，较上期减少6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430302228","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430302228?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:16","pubTimestamp":1714122994,"startTime":"0","endTime":"0","summary":"证券之星消息，近日阳光诺和披露，截至2024年3月31日公司股东户数为3801.0户，较12月31日减少266.0户，减幅为6.54%。在医疗服务行业个股中，阳光诺和股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.13万户。从股价来看，2023年12月31日至2024年3月31日，阳光诺和区间跌幅为10.81%，在此期间股东户数减少266.0户，减幅为6.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600040014.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430621982","title":"阳光诺和2023年营收9.32亿净利1.85亿 董事长利虔薪酬150.02万","url":"https://stock-news.laohu8.com/highlight/detail?id=2430621982","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2430621982?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:36","pubTimestamp":1714109792,"startTime":"0","endTime":"0","summary":"挖贝网4月26日，阳光诺和 近日发布2023年年度报告，报告期内公司实现营业收入932,120,363.16元，同比增长37.76%；归属于上市公司股东的净利润184,757,441.33元，同比增长18.08%。报告期内经营活动产生的现金流量净额为92,861,292.95元，归属于上市公司股东的净资产1,040,012,428.09元。公告显示，报告期内董事、监事、高级管理人员报酬合计18,216,213.99元。截至2023年12月31日，公司总股本为112,000,000股，以此计算拟派发现金红利合计18,480,000.00元（含税）。如后续总股本发生变化，将另行公告具体调整情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042613374887b20947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042613374887b20947&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430317294","title":"太平洋：给予阳光诺和买入评级，目标价位85.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430317294","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430317294?lang=zh_cn&edition=full","pubTime":"2024-04-26 10:59","pubTimestamp":1714100360,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司周豫近期对阳光诺和进行研究并发布了研究报告《Q1业绩超预期，毛利率提升显著》，本报告对阳光诺和给出买入评级，认为其目标价位为85.00元，当前股价为54.34元，预期上涨幅度为56.42%。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042611015787b19624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042611015787b19624&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430029431","title":"太平洋给予阳光诺和买入评级 Q1业绩超预期 毛利率提升显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2430029431","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430029431?lang=zh_cn&edition=full","pubTime":"2024-04-26 10:56","pubTimestamp":1714100212,"startTime":"0","endTime":"0","summary":"太平洋04月26日发布研报称，给予阳光诺和买入评级。评级理由主要包括：1）全年临床业务增长强劲，23Q4销售费用拖累利润增速；2）不断加大研发投入，人才队伍持续扩充；3）新签及在手订单高增长，未来业绩确定性强。AI点评：阳光诺和近一个月获得1份券商研报关注，买入1家，平均目标价为85元，与最新价54.34元相比，高30.66元，目标均价涨幅56.42%。文章来源：每日经济新闻太平洋给予阳光诺和买入评级，Q1业绩超预期，毛利率提升显著","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261059178b5542fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261059178b5542fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430484295","title":"阳光诺和创2月新低 Q4净利同比下降50.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430484295","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2430484295?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:37","pubTimestamp":1714095447,"startTime":"0","endTime":"0","summary":"消息解读阳光诺和2023年年报显示，公司主营收入9.32亿元，同比上升37.76%；归母净利润1.85亿元，同比上升18.08%；扣非净利润1.8亿元，同比上升26.67%。北向资金方面，阳光诺和04月25日获得北向资金增持7.12万股，截至04月25日，北向资金当前共持有阳光诺和49.85万股，市值2740万元，持股占流通股比为0.61%。最新财报显示，今年一季报，阳光诺和实现营业收入2.52亿元，同比增长8.53%，净利润为7,275.38万元，同比增长51.77%，基本每股收益为0.65元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260953527a55e9ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260953527a55e9ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430627552","title":"阳光诺和：延续业绩高增长 深化布局亮点纷呈","url":"https://stock-news.laohu8.com/highlight/detail?id=2430627552","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2430627552?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:44","pubTimestamp":1714092292,"startTime":"0","endTime":"0","summary":"在2023年度，阳光诺和坚守技术创新和成本优化两大核心战略，成功实现了营业收入和净利润的双增长。公司两大业务板块，药学研究服务实现营业收入5.69亿元，同比增长28.67%；临床试验及生物分析服务实现营业收入3.62亿元，同比增长54.54%。持续的研发投入带来客户及订单的持续增长，报告期内，公司新签订单金额达15.04亿元，增长率达36.50%，累计存量订单25.66亿元，同比增长28.69%。公司表示，未来将围绕临床前+临床研究一体化战略，持续深化融合发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260844568b54cdec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260844568b54cdec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430230944","title":"图解阳光诺和一季报：第一季度单季净利润同比增51.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430230944","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430230944?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:10","pubTimestamp":1714068637,"startTime":"0","endTime":"0","summary":"证券之星消息，阳光诺和2024年一季报显示，公司主营收入2.52亿元，同比上升8.53%；归母净利润7275.38万元，同比上升51.77%；扣非净利润6662.01万元，同比上升41.68%；负债率49.33%，投资收益15.93万元，财务费用195.98万元，毛利率59.58%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600002967.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430723498","title":"图解阳光诺和年报：第四季度单季净利润同比减50.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430723498","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430723498?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:47","pubTimestamp":1714063676,"startTime":"0","endTime":"0","summary":"证券之星消息，阳光诺和2023年年报显示，公司主营收入9.32亿元，同比上升37.76%；归母净利润1.85亿元，同比上升18.08%；扣非净利润1.8亿元，同比上升26.67%；其中2023年第四季度，公司单季度主营收入2.4亿元，同比上升32.39%；单季度归母净利润1368.09万元，同比下降50.37%；单季度扣非净利润1223.38万元，同比下降43.55%；负债率43.25%，投资收益129.13万元，财务费用499.53万元，毛利率56.68%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260101038b53ca73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260101038b53ca73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430538280","title":"阳光诺和(688621.SH)发布一季度业绩，净利润7275.38万元，同比增长51.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430538280","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430538280?lang=zh_cn&edition=full","pubTime":"2024-04-25 23:02","pubTimestamp":1714057355,"startTime":"0","endTime":"0","summary":"阳光诺和(688621.SH)发布2024年第一季度报告，公司营业收入2.52亿元...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/astock/24.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/24.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110859.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430428443","title":"阳光诺和：2024年第一季度净利润约7275万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430428443","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430428443?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:12","pubTimestamp":1714054328,"startTime":"0","endTime":"0","summary":"每经AI快讯，阳光诺和 4月25日晚间发布一季度业绩公告称，2024年第一季度营收约2.52亿元，同比增加8.53%；归属于上市公司股东的净利润约7275万元，同比增加51.77%；基本每股收益0.65元，同比增加51.16%。阳光诺和的董事长是利虔，男，43岁，学历背景为大专；总经理是刘宇晶，男，42岁，学历背景为大专。截至发稿，阳光诺和市值为65亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252221428b535b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252221428b535b61&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430233189","title":"注意！阳光诺和将于5月16日召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2430233189","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430233189?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:05","pubTimestamp":1714053948,"startTime":"0","endTime":"0","summary":"阳光诺和4月25日发布公告称，2024年5月16日15点30分，公司将在北京市昌平区科技园区双营西路79号院29号楼公司会议室召开2023年年度股东大会。本次股东大会将审议《关于  的议案》等议案，2024年5月13日收市后登记在册的股东可现场参会投票，或通过交易所投票系统行使表决权。2023年1至12月份，阳光诺和的营业收入构成为：CRO业务占比99.88%。截至发稿，阳光诺和市值为65亿元。阳光诺和将于5月16日召开股东大会","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252340558b53986d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252340558b53986d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430408235","title":"阳光诺和：2023年度净利润约1.85亿元 同比增加18.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430408235","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430408235?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:05","pubTimestamp":1714053939,"startTime":"0","endTime":"0","summary":"阳光诺和（SH 688621，收盘价：57.88元）4月25日晚间发布年度业绩报告称，2023年营业收入约9.32亿元，同比增加37.76%；归属于上市公司股东的净利润约1.85亿元，同比增加18.08%；基本每股收益1.65元，同比增加17.86%。阳光诺和的董事长是利虔，男，43岁，学历背景为大专；总经理是刘宇晶，男，42岁，学历背景为大专。截至发稿，阳光诺和市值为65亿元。文章来源：每日经济新闻原标题：阳光诺和：2023年度净利润约1.85亿元，同比增加18.08%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042523505987afded4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042523505987afded4&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-21","address":"北京市昌平区科技园区双营西路79号院7号楼一层","stockEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0942},{"period":"3month","weight":-0.0762},{"period":"6month","weight":-0.1418},{"period":"1year","weight":-0.1791},{"period":"ytd","weight":-0.1921}],"companyName":"北京阳光诺和药物研究股份有限公司","boardCode":"AI0073","perCapita":"21337股","boardName":"研究和试验发展","registeredCapital":"11200万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　北京阳光诺和药物研究股份有限公司主营业务是为医药企业提供专业化研发外包服务，致力于协助中国医药制造企业加速实现进口替代和自主创新。公司的主要服务是为药学研究服务、临床试验和生物分析服务。","serverTime":1714763334371,"listedPrice":26.89,"stockholders":"3801人(较上一季度减少6.54%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阳光诺和(688621)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阳光诺和(688621)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阳光诺和,688621,阳光诺和股票,阳光诺和股票老虎,阳光诺和股票老虎国际,阳光诺和行情,阳光诺和股票行情,阳光诺和股价,阳光诺和股市,阳光诺和股票价格,阳光诺和股票交易,阳光诺和股票购买,阳光诺和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阳光诺和(688621)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阳光诺和(688621)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}